NDC 76420-778 – Lubiprostone
Lubiprostone 24 ug/1 · Capsule · Oral
Product NDC76420-778
Product details
- Brand name
- Lubiprostone
- Generic name
- Lubiprostone
- Labeler
- Asclemed USA, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA214131
- Marketed since
- March 23, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Chloride Channel Activator
Active ingredients
- Lubiprostone 24 ug/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 76420-778-01 | 100 CAPSULE in 1 BOTTLE (76420-778-01) | Feb 7, 2025 |
| 76420-778-30 | 30 CAPSULE in 1 BOTTLE (76420-778-30) | Feb 7, 2025 |
| 76420-778-60 | 60 CAPSULE in 1 BOTTLE (76420-778-60) | Feb 7, 2025 |
| 76420-778-90 | 90 CAPSULE in 1 BOTTLE (76420-778-90) | Feb 7, 2025 |
Other Lubiprostone products
- 65162-842 Lubiprostone 24 ug/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-841 Lubiprostone 8 ug/1 · Capsule · Amneal Pharmaceuticals LLC
- 76420-777 Lubiprostone 8 ug/1 · Capsule · Asclemed USA, Inc.
- 31722-403 Lubiprostone .008 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 31722-404 Lubiprostone .024 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 72603-288 Lubiprostone .008 mg/1 · Capsule · Northstar Rx LLC
- 72603-289 Lubiprostone .024 mg/1 · Capsule · Northstar Rx LLC
- 70771-1763 Lubiprostone 8 ug/1 · Capsule · Zydus Lifesciences Limited
- 70771-1764 Lubiprostone 24 ug/1 · Capsule · Zydus Lifesciences Limited
- 70710-1641 Lubiprostone 8 ug/1 · Capsule · Zydus Pharmaceuticals USA Inc.
- 70710-1642 Lubiprostone 24 ug/1 · Capsule · Zydus Pharmaceuticals USA Inc.
- 80425-0354 Lubiprostone 8 ug/1 · Capsule, Gelatin Coated · Advanced Rx of Tennessee, LLC